U.S. Wireless Telecom Stock News

NasdaqGS:AGYS
NasdaqGS:AGYSSoftware

Agilysys (AGYS) Valuation Check As Subscription Growth And Hospitality Focus Drive Mixed Returns

Agilysys stock: context for recent performance Agilysys (AGYS) has drawn investor attention after recent share price moves, with the stock showing mixed returns over the past month and past 3 months while longer term performance remains varied. See our latest analysis for Agilysys. At a share price of US$70.81, Agilysys has seen a 1-day share price return of 1.80% and a 7-day share price return of 3.39%, set against a 90-day share price return of 41.72% and a 1-year total shareholder return...
NasdaqGS:FRSH
NasdaqGS:FRSHSoftware

Is Freshworks (FRSH) Now An Opportunity After A 48% One-Year Share Price Slide

Wondering whether Freshworks is starting to look like value or a value trap? This article breaks down what the current share price might really be offering you. The stock last closed at US$8.03, with returns of 8.2% over 30 days but a 48.3% decline over the past year that may have changed how investors view its risk and reward profile. Recent coverage has focused on Freshworks as a mid cap software name that is still trying to win investor confidence after a 30.8% year to date decline and a...
NYSE:XPEV
NYSE:XPEVAuto

XPeng (NYSE:XPEV) Turns Quarterly EPS Positive Challenging Longstanding Profitability Concerns

XPeng (NYSE:XPEV) closed FY 2025 with fourth quarter revenue of C¥22.3b and basic EPS of C¥0.40, while trailing twelve month figures show total revenue of C¥76.7b and a basic EPS loss of C¥1.20, keeping the story firmly focused on scale over the bottom line. The company’s quarterly revenue moved from C¥10.1b in Q3 2024 to C¥22.3b in Q4 2025, with basic EPS shifting from a C¥1.91 loss to C¥0.40, so the latest results sit against a backdrop of expanding sales and still thin margins that...
NYSE:KNX
NYSE:KNXTransportation

How A Tightening Truckload Labor Market At Knight-Swift (KNX) Has Changed Its Investment Story

Earlier this week, an analyst at UBS upgraded Knight-Swift Transportation Holdings after observing signs of a tightening truckload market, including fewer new commercial driver licenses since late 2025. This shift in labor supply highlights how changes in driver availability can influence expectations for freight capacity, pricing power, and earnings for large carriers like Knight-Swift. Next, we’ll explore how the apparent tightening in truckload capacity interacts with Knight-Swift’s...
NasdaqGS:WB
NasdaqGS:WBInteractive Media and Services

Weibo (WB) Valuation Check After Mixed Q4 Earnings AI Ad Progress And New Dividend

Q4 earnings, AI advertising progress, and a new dividend draw focus to Weibo Weibo (WB) is back in focus after its latest quarterly results, which combined modest topline growth with a Q4 net loss, softer non GAAP earnings, and a fresh annual cash dividend declaration. See our latest analysis for Weibo. Despite the AI advertising push and fresh dividend, momentum in the shares has been weak, with a 7 day share price return of 11.18% and a 1 year total shareholder return of a 4.72% loss,...
NasdaqGS:HIMX
NasdaqGS:HIMXSemiconductor

Assessing Whether Himax Technologies (HIMX) Shares Look Stretched After Recent Volatility

What recent performance says about Himax Technologies (HIMX) Himax Technologies (HIMX) has drawn fresh attention after a mixed stretch in the market, with a 4.4% one day decline and a 12.7% pullback over the past week, in contrast with positive returns over the past month and past three months. See our latest analysis for Himax Technologies. That recent weak share price momentum sits alongside a 14.7% 1 month share price return and a 5.6% 1 year total shareholder return. This suggests...
NYSE:HCA
NYSE:HCAHealthcare

Is It Time To Reassess HCA Healthcare (HCA) After Recent Share Price Pullback?

If you are looking at HCA Healthcare and wondering whether the current share price still offers value, the recent numbers give you quite a bit to think about. The stock closed at US$493.88, with returns of 5.0% year to date and 51.2% over 1 year, while the last 7 and 30 days showed pullbacks of 7.3% and 7.7%. Recent coverage around HCA Healthcare has focused on its scale as a major hospital operator and its role in the broader US healthcare system. This often shapes how investors think about...
NYSE:SM
NYSE:SMOil and Gas

Is SM Energy (SM) Pricing Reflect Recent Surge And Civitas Merger Expectations Accurately

If you are wondering whether SM Energy at around US$30.04 offers value or is just noise in a volatile sector, this breakdown will help you size up the stock with a clear valuation lens. The share price shows sharp recent moves, with returns of 12.1% over 7 days, 28.4% over 30 days, 57.0% year to date and 2.4% over the past year. These shifts can change how the market is pricing in both growth potential and risk. Recent coverage has focused on SM Energy's position within the US energy space...
NYSE:SARO
NYSE:SAROAerospace & Defense

Assessing StandardAero’s (SARO) Valuation After New Robinson Helicopter MRO Agreement

StandardAero (SARO) has agreed to provide maintenance, repair, and overhaul services for Robinson Helicopter Company’s global R66 fleet powered by Rolls Royce RR300 engines, giving R66 operators a manufacturer recommended MRO partner. See our latest analysis for StandardAero. The new Robinson Helicopter agreement comes as StandardAero’s share price, now at US$25.60, has recorded a 30 day share price return of 18.11% decline and a year to date share price return of 13.63% decline, with a 1...
NYSE:OPLN
NYSE:OPLNCommercial Services

Should OPENLANE’s Revenue Beat but Softer EPS Outlook Reshape How OPLN Investors View Profit Potential?

Earlier this week, OPENLANE, Inc. reported US$494.3 million in revenue for the latest period, an 8.6% year-on-year increase that exceeded analyst expectations by 4.4%, while also presenting at the Bank of America Global Automotive Summit with CEO Peter J. Kelly and CFO Bradley Herring. Despite the revenue beat, the company’s shortfall versus analysts’ full-year EPS guidance and estimates highlighted ongoing profitability pressures even as management pointed to strong execution and strategic...
NYSE:NVR
NYSE:NVRConsumer Durables

Is NVR (NVR) Offering An Opportunity After Recent Share Price Weakness?

If you are trying to work out whether NVR at around US$6,369.38 is a bargain or a value trap, it helps to start with the recent share price path and what the current valuation signals are really saying. The stock has seen a 1.5% decline over the last week, a 15.3% decline over the past month, and is down 12.5% year to date, while the 1 year return sits at an 11.3% decline and the 3 and 5 year returns are 17.7% and 34.9% respectively. Recent coverage has focused on how NVR's share price...
NYSE:AR
NYSE:AROil and Gas

Is It Time To Reassess Antero Resources (AR) After Its Strong Recent Share Price Run

If you are wondering whether Antero Resources at around US$43.09 is offering fair value or not, it helps to step back and look at what the recent share performance is actually telling you. The stock has returned 5.1% over the last week, 27.3% over the last month and 26.0% year to date, while the 1 year return sits at 5.7% and the 3 year return is 98.4%. Recent coverage has focused on Antero Resources within broader discussions of US energy producers and investor interest in gas focused...
NYSE:LOW
NYSE:LOWSpecialty Retail

Is Lowe’s (LOW) Still Fairly Priced After Recent 20% Monthly Share Price Drop?

Wondering if Lowe's Companies at around US$224 per share still offers value, or if most of the opportunity is already priced in. The stock is roughly flat over 1 year with a 0.9% return, but that sits alongside a 5.5% decline over the last 7 days and a 20.4% decline over the last 30 days, leaving the year to date return at a 9.0% decline. These recent moves come as investors continue to reassess large U.S. retailers and home improvement names in light of shifting consumer demand and...
NasdaqGS:BRZE
NasdaqGS:BRZESoftware

Is It Time To Reassess Braze (BRZE) After A 50% Share Price Slide?

Wondering whether Braze at US$18.33 is starting to look like value or still carries too much risk? This article breaks down what the current price may be implying about the company. The stock has been volatile, with a 2.3% decline over the last 7 days, a 6.7% gain over the last 30 days, a 43.7% fall year to date, and a 50.5% decline over the last year. These moves have come as investors continue to reassess higher growth software names, with attention on how quickly companies can balance...
NYSE:SPGI
NYSE:SPGICapital Markets

Is It Too Late To Consider S&P Global (SPGI) After Recent Share Price Recovery?

Wondering whether S&P Global at around US$424 per share still offers value, or if the best part of the opportunity has passed, starts with a clear look at what you are paying for its future cash flows. The stock has returned 0.5% over the past week and 1.2% over the past month, but sits on a year to date return of 17.2% decline and a 14.1% decline over the past year, alongside longer term 3 year and 5 year returns of 30.0% and 23.1% respectively. Recent coverage of S&P Global has focused on...
NYSE:WES
NYSE:WESOil and Gas

Should Western Midstream’s Bigger Payout Amid Throughput Headwinds Require Action From WES Investors?

Western Midstream Partners recently raised its Q1 2026 cash distribution to US$0.93 per unit, implying an annualized payout of US$3.72, while also reporting record full-year 2025 adjusted EBITDA and free cash flow despite softer Q4 results. The decision to boost the payout while throughput faces headwinds from reduced drilling underscores management’s confidence in the partnership’s cash generation and capital projects such as the Pathfinder water pipeline and North Loving II processing...
NasdaqGS:TYRA
NasdaqGS:TYRABiotechs

Boone Capital Backs Tyra Biosciences As FGFR3 Trials Shape Outlook

Boone Capital Management has disclosed a significant new position in Tyra Biosciences. The investment comes as Tyra Biosciences advances multiple clinical trials centered on FGFR3 biology. The move highlights fresh institutional interest in NasdaqGS:TYRA at a current share price of $37.15. For readers tracking Tyra Biosciences, the company now sits at a share price of $37.15 with substantial recent share price momentum, including a 26.4% return over the past 30 days and 38.7% year to date...
NYSE:PL
NYSE:PLProfessional Services

Planet Labs (PL) Q4 Loss Deepens To US$0.48 EPS Challenging Bullish Growth Narratives

Planet Labs PBC (PL) has just closed out FY 2026 with fourth quarter revenue of US$86.8 million and a basic EPS loss of US$0.48. Trailing twelve month revenue stood at US$307.7 million and EPS at a loss of US$0.80. Over recent periods, the company has seen quarterly revenue move from US$61.6 million in FY 2025 Q4 to US$66.3 million in FY 2026 Q1, US$73.4 million in Q2, US$81.3 million in Q3 and US$86.8 million in Q4. This has come alongside a sequence of widening quarterly EPS losses from...
NasdaqGM:IDN
NasdaqGM:IDNSoftware

Intellicheck (IDN) Q4 EPS Breakthrough Tests High Growth Narrative Against 87.9x P/E

Intellicheck (IDN) has rounded out FY 2025 with fourth quarter revenue of about US$6.6 million and basic EPS of roughly US$0.08, alongside trailing twelve month revenue of US$22.7 million and EPS of about US$0.07 that reflect a move into positive net income of around US$1.3 million over the year. The company has seen quarterly revenue progress from US$4.9 million in Q1 2025 to US$6.6 million in Q4 2025, with EPS shifting from a small loss of roughly US$0.02 per share early in the year to a...
NasdaqGS:WBD
NasdaqGS:WBDEntertainment

Warner Bros. Discovery’s US$110b Sale To Paramount Skydance Reframes Shareholder Upside

Warner Bros. Discovery (NasdaqGS:WBD) has agreed to be acquired by Paramount Skydance in a cash and stock deal valued at $110b. The transaction includes a record-breaking golden parachute package for CEO David Zaslav as part of the change in control. The deal follows a period of awards recognition for Warner Bros.' recent film slate and is expected to reshape competition among major studios. For investors tracking NasdaqGS:WBD, this $110b agreement comes after a very strong 1 year share...
NasdaqGS:LIN
NasdaqGS:LINChemicals

Linde’s Oshkosh Plant And What It Means For Midwest Growth

Linde plans to build a new industrial gases facility in Oshkosh, Wisconsin. The project is intended to expand supply capacity for industrial customers across the Midwest. The development marks a further investment in regional infrastructure for NasdaqGS:LIN. Linde, trading on NasdaqGS:LIN, is moving ahead with construction of a new industrial gases facility in Oshkosh, Wisconsin, adding to its US footprint. The company’s shares most recently closed at $488.15, with a return of 13.8% year to...
NYSE:GPGI
NYSE:GPGITech

Is GPGI (GPGI) Share Price Outrunning Fundamentals After Recent Volatility?

If you are wondering whether GPGI is attractively priced or already reflecting a lot of optimism, the current share price at US$17.06 raises some useful questions about what you are really paying for. Recent returns are mixed, with the stock up 3.3% over the last week but showing a 27.4% decline over 30 days, an 8.6% decline year to date, and gains of 51.0% over 1 year, 191.8% over 3 years, and 114.8% over 5 years. These moves sit against a backdrop of ongoing coverage that keeps GPGI on...
NasdaqGS:LIVN
NasdaqGS:LIVNMedical Equipment

LivaNova’s Aura6000 FDA Win Reshapes Obstructive Sleep Apnea Opportunity

FDA grants premarket approval to LivaNova's aura6000 System for adult patients with moderate to severe Obstructive Sleep Apnea who do not benefit from standard therapies. The system uses proximal hypoglossal nerve stimulation and is supported by clinical trial data showing meaningful outcomes, including in harder to treat patient groups. LivaNova (NasdaqGS:LIVN) also discloses work on a next generation, MRI compatible version of the aura6000 with additional features. LivaNova, listed on...
NasdaqGM:RICK
NasdaqGM:RICKHospitality

RCI Hospitality Holdings (RICK) One Off US$5.2m Loss Tests Bullish Earnings Narrative

RCI Hospitality Holdings (RICK) FY 2025 earnings at a glance RCI Hospitality Holdings (RICK) has just posted its FY 2025 numbers with Q4 revenue of US$70.9 million and a basic EPS loss of US$0.63, set against trailing 12 month EPS of US$1.23 on revenue of US$279.4 million and earnings growth of 259.1% for the period. Over recent quarters, revenue has moved from US$73.2 million in Q4 2024 to US$71.5 million in Q1 2025, US$65.9 million in Q2, US$71.1 million in Q3 and US$70.9 million in Q4,...